Back to Journals » OncoTargets and Therapy » Volume 7

Nanotetrac targets integrin αvβ3 on tumor cells to disorder cell defense pathways and block angiogenesis

Total article views   Abstract views HTML views PDF downloads Totals
5,818 Dovepress* 4,634 482+ 1,079 5,116
PubMed Central* 3 699 299 702
Totals 4,637 1,181 1,378 5,818
*Since 18 September 2014
+Since July 2016

View citations on PubMed Central and Google Scholar